전반적 발달장애의 한국형 치료 권고안 = 약물치료

목차 (Table of Contents)

• 서론
• 결론
• 권고사항-약물치료
• References

참고문헌 (Reference)

1 Martin A, "Weight and leptin changes among risperi-done-treated youths with autism:6-month prospective data" 161 : 125-1127, 2004

2 Henry CA, "Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors:a chart review" 16 : 187-195, 2006

3 Campbell M, "Treatment of autistic disorder" 35 : 134-143, 1996

4 Chez MG, "Treating autistic spectrum disorders in children:utility of the cholinesterase inhibitor rivastigmine tartrate" 19 : 165-169, 2004

5 Cohen SA, "The effect of a switch to ziprasidone in an adult population with autistic dis-order:chart review of naturalistic,open-label treatment" 65 : 110-113, 2004

6 Steingard RJ, "Sertaline treatment of transition-associated anxiety and agi-tation in children with autistic disorder" 7 : 9-15, 1997

7 Shea S, "Risperidone in the treatment of disruptive behavioral symp-toms in children with autistic and other pervasive developmental disorders" 114 : 634-641, 2004

8 "Research Units on Pediatric Psychopharmacology Autism Network.Randomized,controlled,crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity" 62 : 1266-1274, 2005

9 McCracken JT, "Research Units on Pediatric Psychopharm-acology Autism Network.Risperidone in children with autism and serious behavioral problems" 347 : 314-321, 2002

10 McDougle CJ, "Research Units on Pediatric Psychophar-macology (RUPP) autism network, Background and rationale for an initial controlled study of risperidone" 9 : 201-224, 2000

11 McDougle CJ, "Repetitive thoughts and behavior in pervasive developmental disorders:treatment with serotonin reuptake inhibitors" 30 : 427-435, 2000

12 Barron J, "Relationship of sedative-hypnotic res-ponse to self-injurious behavior and stereotypy by mentally re-tarded clients" 88 : 177-186, 1983

13 Findling RL, "Quetiapine in nine youths with autistic disorder" 14 : 287-294, 2004

14 Scahill L, "Psychopharmacology." Hoboken: Wiley 1102-1122, 2005

15 Campbell M, "Pharmacotherapy in autism:a summary of Research at Bellevue/New York Univer-sity" 3 : 299-307, 1990

16 King BH, "Pharmacological treatment of mood disturbances,aggresion,and self-injury in persons with pervasive developmen-tal disorders" 30 : 39-45, 2000

17 King BH, "Pharmacological treatment of mood disturbances,aggresion and self-injury in persons with pervasive develop-mental disorders" 30 : 439-445, 2000

18 Posey DJ, "Paroxetine in autism" 38 : 111-12, 1999

19 Marosu F, "Paradoxical reactions elicited by diazepam in children with classic autism" 2 : 355-361, 1987

20 Kemner C, "Open-label study of olanzapine in children with pervasive developmental disorder" 22 : 455-460, 2002

21 Martin A, "Open-label que-tiapine in the treatment of children and adolescents with autistic disorder" 9 : 99-107, 1999

22 Malone RP, "Olanzapine versus haloperidol in children with autistic dis-order:an open pilot study" 40 : 887-894, 2001

23 Di Martino A, "Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study" 14 : 207-218, 2004

24 Martin A, "Low dose fluvoxamine treatment of children and adolescents with perva-sive developmental disorders:a prospective,open-label study" 33 : 7-85, 2003

25 Belsito KM, "Lamotrigine therapy for autistic disorder:a randomized double-blind,placebo-controlled trial" 31 : 175-181, 2001

26 Posey DJ, "Guanfacine treatment of hyperactivity and inattention in perva-sive developmental disorders:a retrospective analysis of 80 cases" 14 : 223-241, 2004

27 Hertzman M, "Galantamine in the treatment of adult autism:a re-port of three clinical cases" 33 : 395-398, 2003

28 DeLong GR, "Fluoxetine response in child-ren with autistic spectrum disorders:correlation with familial major affective disorder and intellectual achievement" 44 : 652-659, 2002

29 Handen BL, "Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder" 30 : 245-255, 2000

30 Handen BL, "Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder" 30 : 245-255, 2000

31 Buchsbaum MS, "Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders:a pilot study" 4 : 119-125, 2001

32 King BH, "Double-blind,placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder" 40 : 658-665, 2001

33 Tsai LY, "Comorbid psychiatric disorder of autistic disorder" 26 : 159-163, 1996

34 Jaselskis CA, "Clonidine treatment of hyperactive and impulsive children with autistic disorder" 12 : 322-327, 1992

35 McDougle CJ, "Case series:use of ziprasi-done for maladaptive symptoms in youths with autism" 41 : 921-927, 2002

36 Williams PG, "Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management" 31 : 103-108, 2001

37 Stigler KA, "Aripiprazole for mala-daptive behavior in pervasive developmental disorders" 14 : 455-463, 2004

38 King BH, "An update on pharmacologic treatments for autism spectrum disorders" 15 : 161-175, 2006

39 Owley T, "An open-label trial of escitalopram in pervasive developmental disorders" 44 : 343-348, 2005

40 Barnard L, "A systematic review of the use of atypical antipsychotics in autism" 16 : 93-101, 2002

41 Hardan AY, "A retrospective open trial of adjunc-tive donepezil in children and adolescents with autistic disorder" 12 : 237-241, 2002

42 Hardan AY, "A retrospective assessment of topiramate in children and adolescents with pervasive develop-mental disorders" 14 : 426-432, 2004

43 Corson AH, "A restrospective analysis of Quetiapine in the treatment of pervasive developmental disorder" 65 : 1531-1536, 2004

44 Hollander E, "A placebo controlled crossover trial of li-quid fluoxetine on repetitive behaviors in childhood and adole-scent autism" 30 : 582-589, 2005

45 Posey DJ, "A pilot study of D-cycloserine in subjects with autistic disorder" 161 : 2115-2117, 2004

46 Posey DJ, "A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders" 11 : 267-277, 2001

47 McDougle CJ, "A double-blind,placebo controlled study of flu-ovoxamine in adults with autistic disorders" 31 : 746-750, 1996

48 Gordon CT, "A double-blind comparison of clomipramine,desipramine,and placebo in the treatment of autistic disorder" 50 : 441-447, 1993